Paradoxical downregulation of HLA-A expression by IFNγ associated with schizophrenia and noncoding genes.
Neuronal MHC/HLA regulates the synapses of the central nervous system (CNS). The expression of MHC/HLA is, in turn, regulated by immune cytokines. We were therefore interested in the regulation of schizophrenia-associated HLA antigens, specifically their regulation of expression by interferons. We had previously observed a moderately increased frequency of HLA-A10 expression in schizophrenic patients. While searching for the "true" disease gene near the HLA-A gene, we discovered that homozygosity of the HLA-J M80469 pseudogene allele, in combination with HLA-A10 or HLA-A9, was associated with a high risk of schizophrenia (HLA-A10 relative risk = 29.33, p = 0.00019, patients N = 77, controls N = 214). The allele HLA-J M80468, which codes for interferon-inducible mRNA, conferred protection on carriers of HLA-A9 and HLA-A10 (HLA-A10 relative risk = 0.022, p = 0.00017). Functional analysis revealed that interferon γ (IFNγ) downregulated the expression of HLA-A9 and HLA-A10 in monocytes from HLA-J M80469 homozygous patients but not from carriers of the HLA-J M80468 allele. This is the first demonstration of an inverse effect of IFNγ on HLA expression that is associated with non-coding gene variants and schizophrenia. Our findings suggest that the interferons secreted during acute and chronic infections may interfere in synaptic regulation via neuronal HLA and that this disturbance in synaptic regulation may induce the symptoms of mental illness.
Immunotherapy Research Center IMMUNIS e.V., Muenchen, Germany.
Songhai
S
Gu
Barbara
B
Fellerhoff
Norbert
N
Müller
Barbara
B
Laumbacher
Rudolf
R
Wank
D000328:Adult; D000483:Alleles; D016022:Case-Control Studies; D002478:Cells, Cultured; D015536:Down-Regulation / Q000187:drug effects; D005260:Female; D005786:Gene Expression Regulation; D005787:Gene Frequency; D008040:Genetic Linkage; D005820:Genetic Testing; D015234:HLA-A Antigens / Q000235:genetics* / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000235:genetics / Q000276:immunology; D006650:Histocompatibility Testing; D006720:Homozygote; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology* / Q000494:pharmacology; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011544:Pseudogenes / Q000235:genetics* / Q000276:immunology; D012559:Schizophrenia / Q000235:genetics* / Q000276:immunology; D017422:Sequence Analysis, DNA
D015234:HLA-A Antigens; C039682:HLA-A10 antigen; C037709:HLA-A9 antigen; D015395:Histocompatibility Antigens Class I; D007371:Interferon-gamma